10 Recruiting Atopic Dermatitis Phase 3 Clinical Trials
Active phase 3 studies for atopic dermatitis enrolling across the USA. Verify eligibility and contact site coordinators.
All Atopic Dermatitis studiesPhase 3 Studies for Atopic Dermatitis
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
📍 Clinical Research Center of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
📍 AllerVie Clinical Research — Birmingham, Alabama
View Study & Checklist ➔A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
📍 Clinical Research Center of Alabama — Birmingham, Alabama
View Study & Checklist ➔Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
📍 Regeneron Investigational Site — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
📍 Total Skin and Beauty Derm Ctr /ID# 200548 — Birmingham, Alabama
View Study & Checklist ➔A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
📍 Vital Prospects Clinical Research Institute., PC — Tulsa, Oklahoma
View Study & Checklist ➔A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
📍 Cahaba Dermatology & Skin Health Center /ID# 263855 — Birmingham, Alabama
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
📍 Applied Research Center and Wellness Clinic /ID# 268547 — Little Rock, Arkansas
View Study & Checklist ➔A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
📍 Leo Pharma Investigational site — Birmingham, Alabama
View Study & Checklist ➔A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
📍 Cahaba Dermatology & Skin Health Center — Birmingham, Alabama
View Study & Checklist ➔